Overexpression of Nr2f6 mice has been observed to induce hepatic steatosis in MASLD mouse model, whereas suppression of Nr2f6 was observed to improve IR and hepatic steatosis [46]. Here, NR2F6 is linked to metabolic dysfunction-associated steatotic liver disease.